Biocartis Group Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Roger Moody
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | 6.9yrs |
Board average tenure | 5.9yrs |
Recent management updates
Recent updates
CEO
Roger Moody
less than a year
Tenure
Mr. Roger Moody is Chief Executive Officer of Biocartis Group NV from April 24, 2023. Mr. Moody has experience in the technology and healthcare industry and brings a unique combination of deep knowledge of...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Operating Officer | 4.7yrs | no data | no data | |
Chief Executive Officer | less than a year | no data | no data | |
CFO & Head of Service Delivery | less than a year | no data | no data | |
Chief Technology Officer | 6yrs | no data | no data | |
Chairman of Scientific Advisory Board & Chief Scientific Officer | no data | no data | no data | |
Head of IR & Corporate Communications | no data | no data | no data | |
Head of People & Organization | 8.9yrs | no data | no data | |
Head of R&D and Alliance Management | 11.3yrs | no data | no data | |
Head of Manufacturing & Supply Chain | 7.8yrs | no data | no data | |
Vice President of Business Development | 7.9yrs | no data | no data |
6.9yrs
Average Tenure
55yo
Average Age
Experienced Management: 0R72's management team is seasoned and experienced (6.9 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman of Scientific Advisory Board & Chief Scientific Officer | no data | no data | no data | |
Independent Director | 5.6yrs | €84.00k | no data | |
Independent Chairman of the Board | 6.3yrs | €436.78k | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Non Executive Independent Director | 5.9yrs | €47.50k | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Non-Executive Independent Director | 5.9yrs | €49.50k | no data | |
Member of Scientific Advisory Board | no data | no data | no data |
5.9yrs
Average Tenure
65yo
Average Age
Experienced Board: 0R72's board of directors are considered experienced (5.9 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2023/12/23 17:40 |
End of Day Share Price | 2023/09/25 00:00 |
Earnings | 2023/06/30 |
Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Biocartis Group NV is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Scott Bardo | Berenberg |
Hugo Solvet | Bryan Garnier & Co |
Guy Sips | KBC Securities NV |